[1]
2026. Imlunestrant: A Novel Weapon Against Endocrine-ResistantBreast Cancer. Annals of Comprehensive Oncology and Biomedical Sciences. 1, 1 (Jun. 2026), 17–20. DOI:https://doi.org/10.66765/acobs.2026.004.